Conflicts of Interest
L.B. declares to have served as an SAB member of Sanofi, Ionnis, Pfizer, and NovoNordisk; to have received a research grant from AstraZeneca; to have received speaker fees from Sanofi and Bayer; and to have founded the Spin-Offs Glycardial Diagnostics SL and Ivastatin Therapeutics S (which are not associated with this research). T.P. discloses being a co-founder of Spin-offs Glycardial Diagnostics SL and Ivastatin Therapeutics S (both unrelated to this study). The remaining authors have no competing interest to declare.